Takahashi Y, Ikeda N, Nakajima J, Sawabata N, Chida M, Horio H et al (2016) Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma. World J Surg 40:2178–2185. https://doi.org/10.1007/s00268-016-3580-4

Article  PubMed  Google Scholar 

Woo HY, Rhee H, Yoo JE, Kim SH, Choi GH, Kim DY et al (2022) Lung and lymph node metastases from hepatocellular carcinoma: comparison of pathological aspects. Liver Int 42:199–209. https://doi.org/10.1111/liv.15051

Article  PubMed  CAS  Google Scholar 

Huang A, Yang XR, Chung WY, Dennison AR, Zhou J (2020) Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther 5:146. https://doi.org/10.1038/s41392-020-00264-x

Article  PubMed  PubMed Central  Google Scholar 

Shultz DB, Filippi AR, Thariat J, Mornex F, Loo BW Jr, Ricardi U (2014) Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol 9:1426–1433. https://doi.org/10.1097/jto.0000000000000317

Article  PubMed  Google Scholar 

Su GL, Altayar O, O’Shea R, Shah R, Estfan B, Wenzell C et al (2022) AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma. Gastroenterology 162:920–934. https://doi.org/10.1053/j.gastro.2021.12.276

Article  PubMed  Google Scholar 

Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894–1905. https://doi.org/10.1056/NEJMoa1915745

Article  PubMed  CAS  Google Scholar 

Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI et al (2018) Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173:581-594.e512. https://doi.org/10.1016/j.cell.2018.03.057

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R et al (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545:446–451. https://doi.org/10.1038/nature22364

Article  PubMed  PubMed Central  CAS  Google Scholar 

Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA et al (2013) Tracking the clonal origin of lethal prostate cancer. J Clin Investig 123:4918–4922. https://doi.org/10.1172/jci70354

Article  PubMed  PubMed Central  CAS  Google Scholar 

Turajlic S, Swanton C (2016) Metastasis as an evolutionary process. Science 352:169–175. https://doi.org/10.1126/science.aaf2784

Article  PubMed  CAS  Google Scholar 

Baba Y, Watanabe M, Yoshida N, Kawanaka K, Yamashita Y, Baba H (2014) Radiofrequency ablation for pulmonary metastases from gastrointestinal cancers. Ann Thorac Cardiovasc Surg 20:99–105. https://doi.org/10.5761/atcs.ra.13-00343

Article  PubMed  Google Scholar 

Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Lee JJ et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37:1558–1565

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lyu N, Kong Y, Pan T, Mu L, Sun X, Li S et al (2019) Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma. Int J Hyperthermia 36:1003–1011. https://doi.org/10.1080/02656736.2019.1663279

Article  PubMed  CAS  Google Scholar 

Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH et al (2021) Surgical outcome of pulmonary metastasectomy for hepatocellular carcinoma recurrence in liver transplant patients. Ann Transpl 26:e930383. https://doi.org/10.12659/aot.930383

Article  Google Scholar 

Wang L, Ye G, Zhan C, Sun F, Lin Z, Jiang W et al (2019) Clinical factors predictive of a better prognosis of pulmonary metastasectomy for hepatocellular carcinoma. Ann Thorac Surg 108:1685–1691. https://doi.org/10.1016/j.athoracsur.2019.06.086

Article  PubMed  Google Scholar 

Shimizu K, Ohtaki Y, Okumura T, Boku N, Horio H, Takenoyama M et al (2019) Outcomes and prognostic factors after pulmonary metastasectomy in patients with colorectal cancer with previously resected hepatic metastases. J Thorac Cardiovasc Surg 157:2049-2057.e2041. https://doi.org/10.1016/j.jtcvs.2018.12.075

Article  PubMed  Google Scholar 

Choi SH, Lee BM, Kim J, Kim DY, Seong J (2024) Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: a phase II study. J Hepatol 81:84–92. https://doi.org/10.1016/j.jhep.2024.03.003

Article  PubMed  CAS  Google Scholar 

Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr (2010) Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21:S192-203. https://doi.org/10.1016/j.jvir.2010.04.007

Article  PubMed  PubMed Central  Google Scholar 

Rangamuwa K, Leong T, Weeden C, Asselin-Labat ML, Bozinovski S, Christie M et al (2021) Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res 10:2842–2857. https://doi.org/10.21037/tlcr-20-1075

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V et al (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26:987–991. https://doi.org/10.1093/annonc/mdv037

Article  PubMed  PubMed Central  Google Scholar 

Ni Y, Peng J, Yang X, Wei Z, Zhai B, Chi J et al (2021) Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer. Br J Cancer 125:672–678. https://doi.org/10.1038/s41416-021-01404-y

Article  PubMed  PubMed Central  Google Scholar 

Kim K, Kim TH, Kim TH, Seong J (2021) Efficacy of local therapy for oligometastatic hepatocellular carcinoma: a propensity score matched analysis. J Hepatocell Carcinoma 8:35–44. https://doi.org/10.2147/jhc.S290197

Article  PubMed  PubMed Central  Google Scholar 

Li X, Wang J, Li W, Huang Z, Fan W, Chen Y et al (2012) Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. Int J Hyperthermia 28:721–728. https://doi.org/10.3109/02656736.2012.736669

Article  PubMed  CAS  Google Scholar 

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380. https://doi.org/10.1002/hep.29086

Article  PubMed  Google Scholar 

Llovet JM, Lencioni R (2020) mRECIST for HCC: performance and novel refinements. J Hepatol 72:288–306. https://doi.org/10.1016/j.jhep.2019.09.026

Article  PubMed  Google Scholar 

Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer 62:132–137. https://doi.org/10.1016/j.ejca.2016.03.081

Article  PubMed  PubMed Central  Google Scholar 

Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY et al (2022) Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 Edition). Liver Cancer 11:315–328. https://doi.org/10.1159/000523997

Article  PubMed  PubMed Central  Google Scholar 

Demirtas CO, D’Alessio A, Rimassa L, Sharma R, Pinato DJ (2021) ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma. JHEP Rep 3:100347. https://doi.org/10.1016/j.jhepr.2021.100347

Article  PubMed  PubMed Central